Roche developed a research-use-only molecular PCR test to detect Bundibugyo Ebola virus amid the ongoing outbreak in parts of Africa. The work, positioned as a response-support tool, came as external commentary underscored the operational bottlenecks created when diagnostics are not sufficiently fit for purpose for rapid outbreak characterization.